Deborah H. Telman - Jul 25, 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: EVP, Corporate Affairs & GC
Signature: /s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Stock symbol: GILD
Transactions as of: Jul 25, 2024
Transactions value $: -$223,180
Form type: 4
Date filed: 7/26/2024, 05:28 PM
Previous filing: Jun 11, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Tax liability	-$223K	-2.92K	-20.05%	$76.51	11.6K	Jul 25, 2024	Direct
transaction	GILD	Common Stock	Options Exercise		+514	+4.42%		12.1K	Jul 25, 2024	Direct	F1
transaction	GILD	Common Stock	Options Exercise		+8.23K	+67.76%		20.4K	Jul 25, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-514	-1.32%		38.4K	Jul 25, 2024	Common Stock	514		Direct	F1, F2
transaction	GILD	Restricted Stock Unit	Options Exercise		-8.23K	-21.42%		30.2K	Jul 25, 2024	Common Stock	8.23K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3	The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested.